Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exelixis, Inc. (EXEL) since 2002 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exelixis, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 939767.
Total stock buying since 2002: $19,172,979.
Total stock sales since 2002: $314,392,814.
Total stock option exercises since 2002: $121,154,617.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 735,666 | $30,976,923 | 832,087 | $16,164,336 |
| 2024 | 615,000 | $12,666,910 | 872,432 | $24,870,534 | 1,184,849 | $27,369,242 |
| 2023 | 120,409 | $2,602,038 | 790,011 | $15,720,431 | 955,000 | $12,029,098 |
| 2022 | 0 | $0 | 436,562 | $8,413,845 | 525,000 | $2,574,050 |
| 2021 | 0 | $0 | 1,335,658 | $29,298,416 | 1,610,000 | $5,472,649 |
| 2020 | 0 | $0 | 2,145,329 | $47,948,063 | 4,262,623 | $19,133,251 |
| 2019 | 0 | $0 | 2,360,470 | $50,493,429 | 1,819,929 | $9,680,173 |
| 2018 | 0 | $0 | 1,561,698 | $32,260,917 | 1,448,858 | $7,586,210 |
| 2017 | 0 | $0 | 2,246,867 | $53,251,678 | 1,895,509 | $9,574,264 |
| 2016 | 60,000 | $297,920 | 795,219 | $11,897,846 | 1,152,332 | $8,539,362 |
| 2015 | 100,000 | $488,549 | 352,425 | $2,055,775 | 357,633 | $1,984,151 |
| 2014 | 20,000 | $34,200 | 0 | $0 | 23,914 | $0 |
| 2013 | 10,000 | $51,400 | 0 | $0 | 54,270 | $0 |
| 2012 | 35,000 | $156,795 | 7,000 | $35,917 | 54,271 | $0 |
| 2011 | 0 | $0 | 0 | $0 | 121,327 | $0 |
| 2010 | 482,700 | $1,489,754 | 108,539 | $835,207 | 104,427 | $570,120 |
| 2009 | 0 | $0 | 33,835 | $208,447 | 12,500 | $63,000 |
| 2008 | 392,500 | $1,276,125 | 27,213 | $188,239 | 0 | $0 |
| 2007 | 0 | $0 | 119,375 | $1,276,190 | 0 | $0 |
| 2006 | 0 | $0 | 205,624 | $2,114,980 | 65,624 | $414,711 |
| 2005 | 0 | $0 | 325,458 | $2,545,977 | 0 | $0 |
| 2004 | 10,000 | $85,388 | 0 | $0 | 0 | $0 |
| 2002 | 2,000 | $23,900 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-01-08 | Garber Alan M | Option Ex | 11,250 | 4.16 | 46,800 |
| 2019-01-07 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 5,560 | 21.51 | 119,595 |
| 2019-01-07 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 5,560 | 3.79 | 21,072 |
| 2019-01-04 | Morrissey Michael (President and CEO) | Sale | 30,383 | 20.14 | 611,913 |
| 2019-01-04 | Morrissey Michael (President and CEO) | Option Ex | 30,383 | 5.56 | 168,929 |
| 2019-01-03 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 8,000 | 19.95 | 159,600 |
| 2019-01-03 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 8,000 | 1.76 | 14,080 |
| 2019-01-03 | Scangos George A | Sale | 96 | 20.00 | 1,920 |
| 2019-01-03 | Morrissey Michael (President and CEO) | Sale | 3,571 | 20.00 | 71,420 |
| 2019-01-03 | Morrissey Michael (President and CEO) | Option Ex | 3,571 | 5.56 | 19,854 |
| 2019-01-02 | Scangos George A | Sale | 39,904 | 19.64 | 783,714 |
| 2019-01-02 | Morrissey Michael (President and CEO) | Sale | 6,046 | 20.00 | 120,920 |
| 2019-01-02 | Morrissey Michael (President and CEO) | Option Ex | 6,046 | 5.56 | 33,615 |
| 2018-12-03 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 13,499 | 21.02 | 283,748 |
| 2018-12-03 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 13,499 | 5.04 | 68,034 |
| 2018-12-03 | Scangos George A | Sale | 40,000 | 21.16 | 846,400 |
| 2018-11-30 | Senner Christopher J. (EVP and CFO) | Sale | 8,791 | 19.70 | 173,182 |
| 2018-11-30 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 1,943 | 19.91 | 38,685 |
| 2018-11-30 | Scangos George A | Sale | 8,500 | 20.00 | 170,000 |
| 2018-11-29 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 1,116 | 19.51 | 21,773 |
| 2018-11-29 | Scangos George A | Sale | 6,500 | 20.00 | 130,000 |
| 2018-11-28 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 11,759 | 19.12 | 224,832 |
| 2018-11-15 | Morrissey Michael (President and CEO) | Sale | 25,000 | 17.22 | 430,500 |
| 2018-11-15 | Morrissey Michael (President and CEO) | Option Ex | 25,000 | 4.42 | 110,500 |
| 2018-11-07 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 20,000 | 17.32 | 346,400 |
| 2018-11-02 | Morrissey Michael (President and CEO) | Sale | 37,499 | 18.25 | 684,244 |
| 2018-11-02 | Morrissey Michael (President and CEO) | Option Ex | 37,499 | 5.04 | 188,994 |
| 2018-11-01 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 12,000 | 14.16 | 169,920 |
| 2018-11-01 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 12,000 | 5.04 | 60,480 |
| 2018-11-01 | Scangos George A | Sale | 25,000 | 14.57 | 364,250 |
| 2018-10-01 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Sale | 12,000 | 17.77 | 213,240 |
| 2018-10-01 | Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) | Option Ex | 12,000 | 5.04 | 60,480 |
| 2018-10-01 | Scangos George A | Sale | 25,000 | 17.86 | 446,500 |
| 2018-10-01 | Morrissey Michael (President and CEO) | Sale | 12,501 | 17.82 | 222,767 |
| 2018-10-01 | Morrissey Michael (President and CEO) | Option Ex | 12,501 | 5.04 | 63,005 |
| 2018-09-24 | Scangos George A | Sale | 25,000 | 16.85 | 421,250 |
| 2018-09-04 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Sale | 22,500 | 18.53 | 416,925 |
| 2018-09-04 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 22,500 | 5.50 | 123,750 |
| 2018-08-20 | Morrissey Michael (President and CEO) | Sale | 90,000 | 18.20 | 1,638,000 |
| 2018-08-20 | Morrissey Michael (President and CEO) | Option Ex | 90,000 | 5.50 | 495,000 |
| 2018-08-17 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 50,000 | 5.51 | 275,500 |
| 2018-08-15 | Marchesi Vincent T | Sale | 40,000 | 19.50 | 780,000 |
| 2018-08-15 | Marchesi Vincent T | Option Ex | 40,000 | 3.38 | 135,200 |
| 2018-08-10 | Scangos George A | Option Ex | 108,333 | 4.73 | 512,415 |
| 2018-08-09 | Morrissey Michael (President and CEO) | Sale | 34,267 | 20.91 | 716,522 |
| 2018-08-09 | Morrissey Michael (President and CEO) | Option Ex | 34,267 | 1.70 | 58,253 |
| 2018-08-08 | Morrissey Michael (President and CEO) | Sale | 100,000 | 21.02 | 2,102,000 |
| 2018-08-08 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.70 | 170,000 |
| 2018-08-07 | Morrissey Michael (President and CEO) | Sale | 100,000 | 21.10 | 2,110,000 |
| 2018-08-07 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.70 | 170,000 |
| 2018-08-06 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 2,361 | 20.92 | 49,392 |
| 2018-08-01 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Sale | 22,500 | 20.56 | 462,600 |
| 2018-08-01 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 22,500 | 5.50 | 123,750 |
| 2018-07-16 | Morrissey Michael (President and CEO) | Sale | 90,000 | 21.13 | 1,901,700 |
| 2018-07-16 | Morrissey Michael (President and CEO) | Option Ex | 90,000 | 5.50 | 495,000 |
| 2018-07-02 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Sale | 22,500 | 21.20 | 477,000 |
| 2018-07-02 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 22,500 | 5.50 | 123,750 |
| 2018-06-25 | Morrissey Michael (President and CEO) | Sale | 90,000 | 19.62 | 1,765,800 |
| 2018-06-25 | Morrissey Michael (President and CEO) | Option Ex | 90,000 | 5.50 | 495,000 |
| 2018-06-01 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Sale | 22,500 | 20.80 | 468,000 |
| 2018-06-01 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 22,500 | 5.50 | 123,750 |
| 2018-05-31 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 65,000 | 20.71 | 1,346,150 |
| 2018-05-30 | Feldbaum Carl B | Sale | 34,262 | 20.60 | 705,797 |
| 2018-05-30 | Feldbaum Carl B | Option Ex | 14,750 | 4.37 | 64,383 |
| 2018-05-24 | Morrissey Michael (President and CEO) | Sale | 90,000 | 20.55 | 1,849,500 |
| 2018-05-24 | Morrissey Michael (President and CEO) | Option Ex | 90,000 | 5.50 | 495,000 |
| 2018-05-22 | Willsey Lance | Sale | 50,000 | 21.40 | 1,070,000 |
| 2018-05-18 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 3,663 | 21.61 | 79,157 |
| 2018-05-15 | Scangos George A | Option Ex | 15,000 | 11.66 | 174,900 |
| 2018-05-11 | Marchesi Vincent T | Sale | 15,000 | 19.03 | 285,450 |
| 2018-05-11 | Marchesi Vincent T | Option Ex | 15,000 | 11.66 | 174,900 |
| 2018-05-09 | Cohen Charles | Sale | 15,000 | 21.42 | 321,300 |
| 2018-05-09 | Cohen Charles | Option Ex | 15,000 | 11.66 | 174,900 |
| 2018-05-07 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 15,000 | 22.00 | 330,000 |
| 2018-05-07 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 15,000 | 1.90 | 28,500 |
| 2018-05-07 | Papadopoulos Stelios | Sale | 15,000 | 22.15 | 332,250 |
| 2018-05-07 | Papadopoulos Stelios | Option Ex | 15,000 | 11.66 | 174,900 |
| 2018-05-04 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 12,549 | 22.38 | 280,846 |
| 2018-05-04 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 10,000 | 1.90 | 19,000 |
| 2018-05-04 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 20,000 | 22.36 | 447,200 |
| 2018-05-03 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Sale | 22,500 | 22.91 | 515,587 |
| 2018-05-03 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 22,500 | 5.50 | 123,750 |
| 2018-04-27 | Hessekiel Jeffrey (EVP and General Counsel) | Option Ex | 25,000 | 1.70 | 42,500 |
| 2018-04-24 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 20,000 | 1.70 | 34,000 |
| 2018-04-16 | Garber Alan M | Sale | 15,000 | 20.25 | 303,750 |
| 2018-04-16 | Garber Alan M | Option Ex | 15,000 | 11.66 | 174,900 |
| 2018-04-16 | Wyszomierski Jack L | Sale | 14,959 | 20.25 | 302,919 |
| 2018-04-16 | Wyszomierski Jack L | Option Ex | 30,000 | 9.81 | 294,450 |
| 2018-04-11 | Morrissey Michael (President and CEO) | Sale | 90,000 | 20.78 | 1,870,200 |
| 2018-04-11 | Morrissey Michael (President and CEO) | Option Ex | 90,000 | 5.50 | 495,000 |
| 2018-04-06 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 14,591 | 7.18 | 104,763 |
| 2018-03-06 | Marchesi Vincent T | Sale | 15,000 | 24.73 | 370,950 |
| 2018-03-06 | Marchesi Vincent T | Option Ex | 15,000 | 7.97 | 119,550 |
| 2018-03-05 | Feldbaum Carl B | Sale | 11,000 | 23.88 | 262,680 |
| 2018-03-05 | Feldbaum Carl B | Option Ex | 11,000 | 11.66 | 128,260 |
| 2018-03-05 | Cohen Charles | Sale | 15,000 | 24.23 | 363,450 |
| 2018-03-05 | Cohen Charles | Option Ex | 15,000 | 7.97 | 119,550 |
| 2018-03-02 | Willsey Lance | Sale | 30,000 | 23.91 | 717,300 |
| 2018-03-02 | Willsey Lance | Option Ex | 30,000 | 9.81 | 294,450 |
| 2018-03-02 | Papadopoulos Stelios | Sale | 15,000 | 24.05 | 360,750 |
| 2018-03-02 | Papadopoulos Stelios | Option Ex | 15,000 | 7.97 | 119,550 |
| 2018-03-01 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 7,293 | 4.42 | 32,235 |
| 2018-02-28 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 45,029 | 27.13 | 1,221,636 |
| 2018-02-28 | Haley Patrick J. (Sr. Vice President, Commercial) | Option Ex | 13,625 | 3.63 | 49,458 |
| 2018-02-28 | Poste George | Sale | 15,000 | 26.26 | 393,900 |
| 2018-02-28 | Poste George | Option Ex | 15,000 | 11.66 | 174,900 |
| 2018-01-09 | Garber Alan M | Sale | 11,500 | 30.00 | 345,000 |
| 2018-01-09 | Garber Alan M | Option Ex | 11,500 | 7.97 | 91,655 |
| 2018-01-08 | Garber Alan M | Sale | 3,500 | 31.29 | 109,515 |
| 2018-01-08 | Garber Alan M | Option Ex | 3,500 | 7.97 | 27,895 |
| 2017-09-28 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 25,000 | 24.32 | 608,000 |
| 2017-09-28 | Hessekiel Jeffrey (EVP and General Counsel) | Option Ex | 25,000 | 1.90 | 47,500 |
| 2017-09-28 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Sale | 33,334 | 23.74 | 791,349 |
| 2017-09-28 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 33,334 | 9.91 | 330,339 |
| 2017-09-27 | Hessekiel Jeffrey (EVP and General Counsel) | Sale | 2,302 | 23.90 | 55,017 |
| 2017-09-27 | Hessekiel Jeffrey (EVP and General Counsel) | Option Ex | 2,302 | 1.90 | 4,373 |
| 2017-09-27 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Sale | 33,333 | 23.94 | 797,992 |
| 2017-09-27 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 33,333 | 9.91 | 330,330 |
| 2017-09-26 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Sale | 33,333 | 23.68 | 789,325 |
| 2017-09-26 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 33,333 | 9.91 | 330,330 |
| 2017-09-22 | Papadopoulos Stelios | Sale | 10,000 | 25.40 | 254,000 |
| 2017-09-19 | Papadopoulos Stelios | Sale | 127,790 | 27.63 | 3,530,837 |
| 2017-09-18 | Papadopoulos Stelios | Sale | 72,210 | 27.76 | 2,004,549 |
| 2017-09-14 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 60,640 | 27.21 | 1,650,014 |
| 2017-09-14 | Morrissey Michael (President and CEO) | Sale | 100,000 | 27.08 | 2,708,000 |
| 2017-09-14 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.70 | 170,000 |
| 2017-09-13 | Willsey Lance | Sale | 50,000 | 26.97 | 1,348,500 |
| 2017-09-13 | Morrissey Michael (President and CEO) | Sale | 100,000 | 27.04 | 2,704,000 |
| 2017-09-13 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.70 | 170,000 |
| 2017-09-12 | Senner Christopher J. (EVP and CFO) | Sale | 100,000 | 26.79 | 2,679,000 |
| 2017-09-12 | Senner Christopher J. (EVP and CFO) | Option Ex | 100,000 | 3.66 | 366,000 |
| 2017-09-12 | Willsey Lance | Sale | 50,000 | 26.79 | 1,339,500 |
| 2017-09-12 | Morrissey Michael (President and CEO) | Sale | 100,000 | 26.59 | 2,659,000 |
| 2017-09-12 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.70 | 170,000 |
| 2017-05-30 | Haley Patrick J. (Sr. Vice President, Commercial) | Sale | 5,000 | 18.46 | 92,300 |
| 2017-05-15 | Feldbaum Carl B | Sale | 32,988 | 21.58 | 711,881 |
| 2017-05-15 | Feldbaum Carl B | Option Ex | 19,000 | 9.81 | 186,485 |
| 2017-05-15 | Schwab Gisela (Pres Prod Dev & Med Aff & CMO) | Option Ex | 12,501 | 5.04 | 63,005 |
| 2017-05-10 | Morrissey Michael (President and CEO) | Sale | 100,000 | 22.07 | 2,207,000 |
| 2017-05-10 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.80 | 180,000 |
| 2017-05-09 | Morrissey Michael (President and CEO) | Sale | 100,000 | 21.68 | 2,168,500 |
| 2017-05-09 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.90 | 190,000 |
| 2017-05-08 | Morrissey Michael (President and CEO) | Sale | 11,300 | 21.81 | 246,453 |
| 2017-05-08 | Morrissey Michael (President and CEO) | Option Ex | 11,300 | 1.90 | 21,470 |
| 2017-05-05 | Morrissey Michael (President and CEO) | Sale | 100,000 | 21.76 | 2,176,000 |
| 2017-05-05 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.90 | 190,000 |
| 2017-05-04 | Morrissey Michael (President and CEO) | Sale | 59,149 | 22.17 | 1,311,333 |
| 2017-05-04 | Morrissey Michael (President and CEO) | Option Ex | 59,149 | 1.90 | 112,383 |
| 2017-05-03 | Morrissey Michael (President and CEO) | Sale | 100,000 | 22.64 | 2,263,500 |
| 2017-05-03 | Morrissey Michael (President and CEO) | Option Ex | 100,000 | 1.90 | 190,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of EXEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exelixis, Inc. (symbol EXEL, CIK number 939767) see the Securities and Exchange Commission (SEC) website.